Overview

Comparison of Efficacy and Safety of Treatment With a Calcineurin Inhibitor (CNI)Versus a CNI-free Treatment in Renal Transplantation (CIME)

Status:
Unknown status

Trial end date:
2018-08-01

Target enrollment:

Participant gender:

Summary

The main objective of this protocol is to compare the impact on renal function of two different immunosuppressive regimens in patients with de novo renal transplant. Renal function will be accurately evaluated by measuring the clearance of iohexol. The protocol will also evaluate the efficacy and safety in a short term of these two different immunosuppressive regimens.

Phase:

Phase 3

Details

Lead Sponsor:

Centre Hospitalier Universitaire, Amiens

Collaborator:

Novartis

Treatments:

Calcineurin Inhibitors
Cyclosporine
Cyclosporins
Everolimus
Mycophenolate mofetil
Mycophenolic Acid
Sirolimus